CJ Bioscience, Inc. (KOSDAQ:311690)

CJ Bioscience Revenue

CJ Bioscience had revenue of 737.90M KRW in the quarter ending September 30, 2025, a decrease of -0.85%. This brings the company's revenue in the last twelve months to 3.38B, down -14.90% year-over-year. In the year 2024, CJ Bioscience had annual revenue of 3.47B, down -37.82%.

• Revenue (ttm): 3.38B
• Revenue Growth: -14.90%
• P/S Ratio: 32.94
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 111.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.47B	-2.11B	-37.82%
Dec 31, 2023	5.58B	1.50B	36.82%
Dec 31, 2022	4.07B	-288.37M	-6.61%
Dec 31, 2021	4.36B	-948.52M	-17.86%
Dec 31, 2020	5.31B	528.32M	11.05%